Subscribe to 51¾«Æ·ÊÓƵwire Today
Get the most interesting and important stories from the 51¾«Æ·ÊÓƵ.51¾«Æ·ÊÓƵ Professors to Examine COVID-19 Measures’ Impact on Opioid Use Disorder Populations, Providers
The 51¾«Æ·ÊÓƵ, NYU Grossman School of Medicine and the University of Arizona will assess the impact of COVID-19 measures on providers and at-risk opioid use disorder populations in Pennsylvania, New York and Arizona.
Antoine Douaihy, professor of psychiatry and medicine, and Janice Pringle, professor of pharmacy and therapeutics, are leading 51¾«Æ·ÊÓƵ’s efforts.
In 2017, Pennsylvania designated 45 primary care providers, hospitals, community health centers and substance use disorder treatment providers as Centers of Excellence for Opioid Use Disorder. The 51¾«Æ·ÊÓƵ will examine how providers at these whole person, integrated care centers implemented COVID-19-policies related to providing medications for opioid use disorder and telehealth services. The project will look at the impact of temporary COVID-19 policies on opioid use disorder treatment, workforce morale and patient outcomes.
51¾«Æ·ÊÓƵ's researchers received $100,000 as a part of a larger project by the Foundation for Opioid Response Efforts to assess the impact of COVID-19 on opioid use disorder treatment and equity.